New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
09:37 EDTMUX, PAY, ONXX, CELG, CAP, ARIA, VSTM, MDR, AFFY, MSI, ZBRA, PCYC, ALNY, CENTOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Affymax (AFFY) initiated with an Outperform at JMP Securities... Alnylam (ALNY) initiated with an Outperform at JMP Securities... Celgene (CELG) initiated with an Outperform at JMP Securities... DSW (DSW) initiated with a Buy at Sterne Agee... McDermott (MDR) initiated with a Neutral at HSBC... Onyx Pharmaceuticals (ONXX) initiated with an Outperform at JMP Securities... Pharmacyclics (PCYC) initiated with an Outperform at JMP Securities... Verastem (VSTM) initiated with an Outperform at JMP Securities... VeriFone (PAY) initiated with a Hold at Jefferies... sZebra Technologies (ZBRA) initiated with a Market Perform at Wells Fargo... ARIAD (ARIA) initiated with an Outperform at JMP Securities... McEwen Mining (MUX) initiated with a Buy at Stifel Nicolaus... Motorola Solutions (MSI) initiated with an Outperform at Wells Fargo... CAI International (CAP) initiated with an Outperform at Wells Fargo... Central Garden & Pet (CENT) initiated with a Neutral at SunTrust.
News For AFFY;CELG;ALNY;MDR;ONXX;PCYC;VSTM;PAY;ZBRA;ARIA;MUX;MSI;CAP;CENT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 20, 2015
08:47 EDTPCYCPharmacyclics announces positive results from PCYC-1102 study
Pharmacyclics announced that IMBRUVICA follow-up data in treatment-naive, or TN, and relapsed/refractory patients with chronic lymphocytic leukemia or small lymphocytic lymphoma, or CLL and SLL respectively, demonstrated that, with up to 45 months of follow-up, the 94 patients who received IMBRUVICA 420 mg experienced a 91% overall response rate, or ORR, and 14% of all patients achieved a complete response. These data are an analysis of outcomes from the Phase I/IIb study, or PCYC-1102, and the ongoing extension study and were presented in an oral presentation at the American Association of Cancer Research.
07:20 EDTARIAAmerican Association for Cancer Research to hold annual meeting
Subscribe for More Information
07:18 EDTALNYAmerican Academy of Neurology to hold annual meeting
Subscribe for More Information
07:04 EDTMUXMcEwen Mining initiated with a Buy at H.C. Wainwright
Target $1.25.
April 17, 2015
16:50 EDTPCYCAbbVie extends exchange offer to acquire Pharmacyclics
Subscribe for More Information
07:36 EDTARIAARIAD presents updated clinical data on Brigatinib
Subscribe for More Information
April 16, 2015
17:21 EDTMUXMcEwen Mining reports Q1 gold production up 23%
Subscribe for More Information
April 15, 2015
17:08 EDTCELGCelgene announces phase 2 Apremilast data
Subscribe for More Information
April 14, 2015
10:01 EDTPAY, MDROn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:18 EDTALNYAlnylam data encouraging, says JMP Securities
Subscribe for More Information
05:44 EDTPAYVerifone upgraded to Buy from Neutral at Goldman
Subscribe for More Information
05:36 EDTMDRMcDermott upgraded to Outperform from In-Line at Imperial Capital
Imperial Capital upgraded McDermott to Outperform saying the company will benefit from growing demand for offshore oil and gas construction services. The firm raised its price target for shares to $6 from $4.
April 13, 2015
18:18 EDTMUXMcEwen Mining CEO says no regular contact, relationship with cartel members
Subscribe for More Information
14:20 EDTARIANHS Scotland accepts ARIAD's Iclusig for use
Subscribe for More Information
14:07 EDTPCYCEarnings Watch: Johnson & Johnson shares down slightly since last earnings
Subscribe for More Information
11:02 EDTALNYAlnylam publishes pre-clinical results on ALN-AT3
Subscribe for More Information
10:15 EDTALNYHigh option volume stocks
Subscribe for More Information
09:34 EDTCELGActive equity options trading on open
Subscribe for More Information
05:09 EDTCELGCelgene to purchase 14.35M shares of Mesoblast stock for A$3.82 per share
Subscribe for More Information
April 12, 2015
19:33 EDTCELGCelgene takes stake in Australia's Mesoblast, the Australian says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use